FDA’s Latest Communication Project Is Grant Opportunity For Non-profits
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency is offering a modest $200,000 grant to piggyback on efforts by non-profit groups to “foster better understanding of the work of CDER.”
You may also be interested in...
FDA Grades Itself Highly In Reports On Safety Of Imported Products And Marketed Drugs
As Congressional markups of user fee bills looms, the agency describes actions it has taken to protect the international supply chain in its Global Engagement report; another report notes the REMS and drug safety studies it has mandated under its postmarket drug safety program.
FDA Gives Progress Report On Risk Communication Plan
About a year into the implementation of FDA's risk communication plan, the agency has met most of its 2010 goals, such as publishing a risk communication research agenda, designing surveys about public understanding and improving procedures to test communications more quickly.
Janssen’s Sirturo Needs Minor Tweaks To Confirmatory Trial, FDA Panel Says
Gathering more data to assuage concerns about possibly lower efficacy in black patients will be key to converting the accelerated approval to full approval for the tuberculosis drug, FDA’s Anti-Infective Drugs Advisory Committee concludes.